Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,076 | 546 | 99.8% |
| Education | $15.56 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,922 | 104 | $0 (2024) |
| ABBVIE INC. | $1,289 | 71 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $780.99 | 41 | $0 (2024) |
| PFIZER INC. | $554.18 | 34 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $520.72 | 39 | $0 (2024) |
| Lilly USA, LLC | $513.54 | 31 | $0 (2024) |
| GlaxoSmithKline, LLC. | $501.92 | 25 | $0 (2024) |
| Abbott Laboratories | $482.45 | 25 | $0 (2024) |
| Novo Nordisk Inc | $313.09 | 15 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $235.46 | 13 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,342 | 68 | Abbott Laboratories ($267.48) |
| 2023 | $1,545 | 77 | Abbott Laboratories ($214.97) |
| 2022 | $897.07 | 48 | ABBVIE INC. ($197.58) |
| 2021 | $1,514 | 81 | AbbVie Inc. ($508.25) |
| 2020 | $1,058 | 55 | Amgen Inc. ($380.33) |
| 2019 | $1,102 | 66 | Amgen Inc. ($342.93) |
| 2018 | $1,440 | 80 | Amgen Inc. ($330.44) |
| 2017 | $1,194 | 74 | Amgen Inc. ($139.40) |
All Payment Transactions
549 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: Diabetes Care | ||||||
| 12/20/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: WOMENS HEALTH | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: VACCINE | ||||||
| 11/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Vaccines | ||||||
| 11/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Diabetes Care | ||||||
| 11/07/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: ANTI-ANXIETY | ||||||
| 10/29/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Diabetes Care | ||||||
| 10/25/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.31 | General |
| 10/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: ANTI-ANXIETY | ||||||
| 10/08/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Gastroenterology | ||||||
| 09/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Diabetes Care | ||||||
| 09/11/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $26.23 | General |
| 09/04/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 374 | 532 | $56,112 | $24,796 |
| 2022 | 5 | 386 | 582 | $55,563 | $25,882 |
| 2021 | 4 | 421 | 533 | $52,270 | $28,653 |
| 2020 | 6 | 418 | 543 | $46,479 | $20,343 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 140 | 221 | $42,092 | $14,000 | 33.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 106 | 106 | $7,950 | $7,625 | 95.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 105 | 105 | $2,625 | $2,573 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 51 | $1,871 | $548.68 | 29.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 49 | $1,575 | $50.16 | 3.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 156 | 259 | $42,735 | $15,959 | 37.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 101 | 104 | $6,760 | $6,629 | 98.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 102 | 105 | $2,625 | $2,574 | 98.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 57 | $2,018 | $649.92 | 32.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 13 | 57 | $1,425 | $70.57 | 5.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 157 | 242 | $39,930 | $17,940 | 44.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 127 | 127 | $8,240 | $8,240 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 126 | 126 | $3,150 | $2,418 | 76.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 11 | 38 | $950.00 | $54.78 | 5.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 127 | 210 | $34,650 | $11,040 | 31.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 125 | 126 | $6,300 | $6,296 | 99.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 126 | 127 | $3,175 | $2,406 | 75.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 14 | 34 | $1,204 | $334.78 | 27.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 12 | 12 | $300.00 | $226.00 | 75.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2020 | 14 | 34 | $850.00 | $40.69 | 4.8% |
About Dr. Jeffrey Denham, M.D
Dr. Jeffrey Denham, M.D is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477592806.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Denham, M.D has received a total of $10,091 in payments from pharmaceutical and medical device companies, with $1,342 received in 2024. These payments were reported across 549 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($10,076).
As a Medicare-enrolled provider, Denham has provided services to 1,599 Medicare beneficiaries, totaling 2,190 services with total Medicare billing of $99,675. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Pasadena, CA
- Active Since 06/04/2006
- Last Updated 06/19/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477592806
Products in Payments
- Aimovig (Biological) $714.28
- ENTRESTO (Drug) $676.23
- EVENITY (Biological) $667.98
- UBRELVY (Drug) $630.19
- XIFAXAN (Drug) $596.04
- Prolia (Biological) $479.38
- VRAYLAR (Drug) $409.65
- ELIQUIS (Drug) $326.39
- TRELEGY ELLIPTA (Drug) $318.87
- FREESTYLE LIBRE 3 (Device) $299.50
- Trintellix (Drug) $257.79
- Edarbi (Drug) $213.05
- FREESTYLE LIBRE 2 (Device) $182.95
- NURTEC ODT (Drug) $180.56
- EMGALITY (Drug) $177.67
- MOUNJARO (Drug) $152.92
- Vascepa (Drug) $151.35
- Ozempic (Drug) $142.02
- Androgel (Drug) $114.40
- CHANTIX (Drug) $114.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882